Core Laboratories Inc. /DE/ 8-K

What Happened

• Core Laboratories Inc. (CLB) filed an 8-K on February 4, 2026 reporting its financial results for the fourth quarter and full year ended December 31, 2025 via a press release.
• The company also announced a quarterly cash dividend of $0.01 per share of common stock, payable March 9, 2026 to shareholders of record as of February 16, 2026. The press release is attached as Exhibit 99.1 to the filing.

Key Details

• Filing date: February 4, 2026 (Item 2.02: Results of Operations and Financial Condition; Item 7.01: Regulation FD Disclosure).
• Quarterly dividend: $0.01 per share; record date February 16, 2026; payment date March 9, 2026.
• Press release attached as Exhibit 99.1 (information furnished, not “filed” under the Exchange Act).
• Form 8-K signed by Christopher S. Hill, Chief Financial Officer.

Why It Matters

• The earnings press release provides the company’s most recent revenue, profit and operational results for investors to assess performance and trends heading into 2026.
• The declared dividend, while small, signals management’s decision to return some cash to shareholders and is a concrete near-term cash flow item for holders of CLB shares.
• Investors should review the attached press release for the detailed financial metrics (revenue, earnings, guidance if provided) to determine impacts on valuation and near-term expectations.